Professor Andrew Wardley is a Consultant Medical Oncologist specialising in Breast Cancer. He is an internationally renowned expert in breast cancer treatment and research.

His research into breast cancer and is widely published. His clinical research focus surrounds identifying resistance pathways in breast cancer and introducing new treatments, through response directed therapy. He has been the Principal Investigator for many national and international practising changing trials. He led commissioning of many of these into practice in UK and has designed innovative models of cancer care adopted by Europen Code of Cancer Practice and NHS England.

Professor Wardley established Manchester as the go to centre for cancer research in UK, co-founded Manchester Breast Centre, was a major contributer to developing Manchester Cancer Research Centre, Manchester Academic Health Science Centre, and Greater Manchester Cancer. As Medical Director of The NIHR Manchester Clinical Research Facility he developed Early Phase Cancer Clinical Trials Unit to be one of the largest in Europe. This contributed to NIHR Biomedical Research Centre Status and CRUK Major Centre status for Manchester.

MBChB - University of Manchester, UK in 1989

MRCP - Royal College of Physicians, UK in 1993

MSc - University of Manchester, UK in 2000

MD - University of Manchester, UK in 2000

CCST-JCHST Royal Colleges of Physicians, UK 2000

FRCP - Royal College of Physicians of London, UK in 2005